Hong Kong · Delayed Price · Currency is HKD Vigonvita Life Sciences Statistics
Total Valuation
HKG:2630 has a market cap or net worth of HKD 13.61 billion. The enterprise value is 14.12 billion.
| Market Cap | 13.61B |
| Enterprise Value | 14.12B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2630 has 167.60 million shares outstanding. The number of shares has increased by 7.22% in one year.
| Current Share Class | 66.68M |
| Shares Outstanding | 167.60M |
| Shares Change (YoY) | +7.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 63.04% |
| Owned by Institutions (%) | 3.34% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 54.26 |
| PB Ratio | 58.00 |
| P/TBV Ratio | 97.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 56.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 4.22.
| Current Ratio | 1.00 |
| Quick Ratio | 0.98 |
| Debt / Equity | 4.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -33.51% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 714,599 |
| Profits Per Employee | -1.00M |
| Employee Count | 351 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 84.65 |
| 200-Day Moving Average | 85.07 |
| Relative Strength Index (RSI) | 39.98 |
| Average Volume (20 Days) | 92,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2630 had revenue of HKD 250.82 million and -351.85 million in losses. Loss per share was -2.19.
| Revenue | 250.82M |
| Gross Profit | 215.67M |
| Operating Income | -306.36M |
| Pretax Income | -352.75M |
| Net Income | -351.85M |
| EBITDA | -276.59M |
| EBIT | -306.36M |
| Loss Per Share | -2.19 |
Balance Sheet
The company has 468.47 million in cash and 991.07 million in debt, with a net cash position of -522.61 million or -3.12 per share.
| Cash & Cash Equivalents | 468.47M |
| Total Debt | 991.07M |
| Net Cash | -522.61M |
| Net Cash Per Share | -3.12 |
| Equity (Book Value) | 234.63M |
| Book Value Per Share | 1.48 |
| Working Capital | 1.33M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 30.15M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 85.99%, with operating and profit margins of -122.14% and -140.28%.
| Gross Margin | 85.99% |
| Operating Margin | -122.14% |
| Pretax Margin | -140.64% |
| Profit Margin | -140.28% |
| EBITDA Margin | -110.27% |
| EBIT Margin | -122.14% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2630 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.22% |
| Shareholder Yield | -7.22% |
| Earnings Yield | -2.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |